CoChat

Muscle sympathetic nervous activity in depressed patients before and after treatment with sertraline

Scalco, Andréia Zavaloni, Rondon, Maria UPB, Trombetta, Ivani Credidio, Laterza, Mateus Camaroti, Azul, João BCCS, Pullenayegum, Eleanor Maria, Scalco, Mônica Zavaloni, Kuniyoshi, Fátima HS, Wajngarten, Maurício, Negrão, Carlos Eduardo, Lotufo-Neto, Francisco · 2009 · Journal of Hypertension
Cited by 75

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Sympathetic hyperactivity is one of the mechanisms involved in the increased cardiovascular risk associated with depression, and there is evidence that antidepressants decrease sympathetic activity. OBJECTIVES: We tested the following two hypotheses: patients with major depressive disorder with high scores of depressive symptoms (HMDD) have augmented muscle sympathetic nervous system activity (MSNA) at rest and during mental stress compared with patients with major depressive disorder with low scores of depressive symptoms (LMDD) and controls; sertraline decreases MSNA in depressed patients. METHODS: Ten HMDD, nine LMDD and 11 body weight-matched controls were studied. MSNA was directly measured from the peroneal nerve using microneurography for 3 min at rest and 4 min during the Stroop color word test. For the LMDD and HMDD groups, the tests were repeated after treatment with sertraline (103.3 +/- 40 mg). RESULTS: Resting MSNA was significantly higher in the HMDD [29.1 bursts/min (SE 2.9)] compared with LMDD [19.9 (1.6)] and controls [22.2 (2.0)] groups (P = 0.026 and 0.046, respectively). There was a significant positive correlation between resting MSNA and severity of depression. MSNA increased significantly and similarly during stress in all the studied groups. Sertraline significantly decreased resting MSNA in the LMDD group and MSNA during mental stress in LMDD and HMDD groups. Sertraline significantly decreased resting heart rate and heart rate response to mental stress in the HMDD group. CONCLUSION: Moderate-to-severe depression is associated with increased MSNA. Sertraline treatment reduces MSNA at rest and during mental challenge in depressed patients, which may have prognostic implications in this group.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/hjh.0b013e3283310ece

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 75

Metadata

Authors
Scalco, A. Z., Rondon, M. U., Trombetta, I. C., Laterza, M. C., Azul, J. B., Pullenayegum, E. M., Scalco, M. Z., Kuniyoshi, F. H., Wajngarten, M., Negrão, C. E., & Lotufo-Neto, F.
Venue
Journal of Hypertension
Published
2009-12
Volume
27
Issue
12
Pages
2429-2436
ISSN
0263-6352 (ISSN-L)
OpenAlex
W1966317112
Cited by
75
References
10
FWCI
2.37
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Muscle sympathetic nervous activity in depressed patients before and after treatment with sertraline. https://app.cochat.ai/papers/10.1097/hjh.0b013e3283310ece
The paper
Scalco, A. Z., Rondon, M. U., Trombetta, I. C., Laterza, M. C., Azul, J. B., Pullenayegum, E. M., Scalco, M. Z., Kuniyoshi, F. H., Wajngarten, M., Negrão, C. E., & Lotufo-Neto, F. (2009). Muscle sympathetic nervous activity in depressed patients before and after treatment with sertraline. Journal of Hypertension. https://doi.org/10.1097/hjh.0b013e3283310ece

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.